Corticomedullary Differentiation in Fetal Kidneys: A Necessary Evil?
Journal of Fetal Medicine · 01.06.2024 · 11 (02) · 139-144
DOI: 10.1055/s-0044-1787665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fetal Medicine, erschienen am 01.06.2024. Verfasst von Ashutosh Gupta und 5 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Renal corticomedullary differentiation (CMD) is a crucial indicator of fetal renal health and is detectable as early as 15 to 16 weeks of gestation. Abnormalities in CMD, such as accentuation or loss, may signal underlying renal diseases. CMD assessment via prenatal ultrasound evolves dynamically throughout gestation, reflecting changes in cortical echogenicity and cystic structures. While CMD alterations can indicate conditions like glomerulonephritis or obstructive uropathies, they also offer prognostic insights into future renal function. This case report highlights the importance of early detection and comprehensive evaluation of CMD for optimising prenatal renal care.
Zitieren
APA
Gupta, A., Aneja, A., Bahl, N., Arora, R., Nadir, L., & Saini, P. (2024). Corticomedullary Differentiation in Fetal Kidneys: A Necessary Evil?. Journal of Fetal Medicine, 11(02), 139-144. https://doi.org/10.1055/s-0044-1787665
Vancouver
Gupta A, Aneja A, Bahl N, Arora R, Nadir L, Saini P. Corticomedullary Differentiation in Fetal Kidneys: A Necessary Evil?. Journal of Fetal Medicine. 2024;11(02):139-144. doi:10.1055/s-0044-1787665
BibTeX
@article{Gupta2024,
author = {Gupta, Ashutosh and Aneja, Anjila and Bahl, Neena and Arora, Rupam and Nadir, Loveleena and Saini, Pankaj},
title = {Corticomedullary Differentiation in Fetal Kidneys: A Necessary Evil?},
journal = {Journal of Fetal Medicine},
year = {2024},
volume = {11},
number = {02},
pages = {139--144},
doi = {10.1055/s-0044-1787665}
}
EUVIMED